We sought to elucidate the role of imbalanced mitochondrial dynamics in calcium oxalate nephrolithiasis and the ameliorative effect of PPARγ agonist treatment on mitochondrial damage in TECs. Here, PPARG is linked to Calcium oxalate nephrolithiasis.